Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil

International Journal of Impotence Research

Volumn 19, Issue 1, 2007, Pages 110-113

  Haaga, J R ^a   Exner, A ^a   Fei, B ^a   Seftel, A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Angiogenesis; Prostate blood flow; Vasoactive drugs

Indexed keywords

GADOLINIUM; GADOLINIUM VERSETAMIDE; PSEUDOEPHEDRINE; SILDENAFIL; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD FLOWMETRY; BLOOD VESSEL REACTIVITY; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG ABSORPTION; DRUG EFFECT; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; QUANTITATIVE ANALYSIS; REFERENCE VALUE; VASOCONSTRICTION; VASODILATATION;

BLOOD FLOW VELOCITY; EPHEDRINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSTATE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 33846065570     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901486     Document Type: Article

References (18)

1. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - initial experience. Radiology 2004; 233: 709-715.
2. Sommer FG, Nghiem HV, Herfkens R, McNeal J. Gadolinium-enhanced MRI of the abnormal prostate. Magn Reson Imaging 1993; 11: 941-948.
3. Preziosi P, Orlacchio A, Di Giambattista G, Di Renzi P, Bortolotti L, Fabiano A, Cruciani E, Pasqualetti P. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 2003; 13: 925-930.
4. Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005; 53: 249-255.
5. Padhani AR, Gapinski CJ, MacVicar DA, Parker GJ, Suckling J, Revell PB et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55: 99-109.
6. Oyen RH. Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma? Eur Radiol 2003; 13: 921-924.
7. Mattsson J, Lilja J, Peterson HI. Influence of vasoactive drugs on local tumor blood flow. Eur J Cancer Clin Oncol 1982; 18: 677-684.
8. Mattson J, Appelgren L, Karlsson L, Peterson HI. Influence of vasoactive drugs and ischaemia on intra-tumour blood flow distribution. Eur J Cancer 1978; 14: 761-764.
9. Hori K, Zhang QH, Saito S, Tanda S, Li HC, Suzuki M. Microvasculare mechanisms of change in tumor blood flow due to aniotensin II, epinephrine and methoxamine: a functional morphometric study. Cancer Res 1993; 53: 5528-5534.
10. Zlotecki RA, Baxter LT, Boucher Y, Jain RK. Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvasc Res 1995; 50: 429-443.
11. Medina P, Segarra G, Vila J, Domenech C, Martinez-Leon JB, Lluch S et al. Effects of sildenafil on human penile blood vessels. Urology 2000; 56: 539-543.
12. Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology 1993; 42: 51-53.
13. Uckert S, Oelke M, Stief CG, Andersson KE, Jonas U, Hedlund P. Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE)isoenzymes in the human prostate. Eur Urol 2006; Jan 18 [E-pub ahead of print].
14. Preston A, Frydenberg M, Haynes JM. A1 and A2A adenosine receptor modulation of alpha 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells. Br J Pharmacol 2004; 141: 302-310.
15. Sadeghi-Nejad H, Dogra V, Seftel AD, Mohamed MA. Priapism. Radiol Clin North Am 2004; 42: 427-443.
16. Eberhard A, Kahlert S, Goede V, Bernhard H, Hemmerlein B, Plate KH et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000; 60: 1388-1393.
17. Haaga J. Interventional CT: 30 years experience. Eur Radiol 2005; 15: D116-D120.
18. Qian C, Takahashi M, Kahnoski RJ, Teh BT. Effect of sildenafil citrate on an orthotopic prostate cancer growth and metastasis model. J Urol 2003; 170: 994-997.